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ABSTRACT
One of the chronic progressive disorders of the spinal cord in dogs is the degenerative myelopathy (DM). The 
most predisposed age in dog is 5 to 14 years, while rarely noted in younger, there is no gender predisposition. This 
disorder most commonly appears in dogs of the German shepherd breed, but it can appear in other breeds too. 
The main changes about this disease are degeneration of the myelin, especially in the thoracic-lumbar segments 
of the spinal cord and the dorsal nerve roots. The progression of the disease is slow and can last months to years. 
Undoubtedly, diagnosis is made by examinations of the CSF and establishing elevated level of protein segments.
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INTRODUCTION 
Spinal disruptions can be caused by anomalies, 
degenerative conditions, tumors, inﬂ  ammations, ex-
ternal trauma, internal trauma as result of disc dis-
location and infarction. One of the most common 
chronic progressive disruptions if the spinal cord in 
dogs is Degenerative myelopathy (DM). This dis-
order is characterized with myelin and axon loss, 
generally present in adult animals. 
Degenerative myelopathy in dogs has been 
known for more that 35 years, mostly apparent in 
patients between 5 and 14 years, not often in young-
er dogs (1). At the beginning this disease was mend 
to be speciﬁ  c for German shepherds and was called 
German shepherd myelopathy (2). Later it had been 
named chronic degenerative reticulomyelopathy, 
because changes in nerve’s roots were noticed, that 
was used as explanation of the present hyporeﬂ  exy 
(7). Latest examinations showed that DM can be 
present in other breeds too. The disease have been 
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described in this breeds Pembroke Welsh Corgi, 
Boxer, Rhodesian  Ridgeback , English foxhound, 
Retriever, Jack Resell  terrier, Afghanistan  hound 
and Pyrenean  Mountain dog (3). In dog’s DM there 
is no sexual predisposition; ﬁ  rst clinical signs of the 
disease are related with covert progressive ataxia 
and paresis of the lower limbs, which in a period of 
6-12 mounts leads to loss of ability to stand. (1, 2, 
4). In this stage of the disease, examination of spinal 
reﬂ  exes indicates paresis of the upper motor neu-
rons. It’s typically the function of the higher limbs, 
the urinary and fecal incontinence are not present 
until the last stages (5).  
Conventional diagnostic test for affected dogs 
are: radiography, myelography and cerebrospinal 
liquid analyses. Most sensitive diagnostic method 
for describing spinal morphology is computer to-
mography. (23)
The clinical parameters are generally in physi-
ological ranges, except increased protein level in the 
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cerebrospinal ﬂ  uid in the lumbar cistern. The pro-
teins that are measured in the cerebrospinal liquor 
are: myelin basic protein MBP (17, 18), S-100 and 
C-reactive protein, which in the later phases is used 
for differencing the bacterial from viral meningoen-
cephalitis (19, 20). Myelin basic protein had been 
examined by some authors, who revealed increased 
MBP concentration in cerebrospinal ﬂ  uid taken from 
lumbar cistern from dogs with DM, but not in the 
cerebrospinal liquor from cistern magna (18). These 
ﬁ  ndings showed that there are active demyelination 
changes in the spinal cord. In these studies is also 
conﬁ  rmed the relation between MBP and the demy-
elination degree in the affected animals (18). These 
tests have limited availability and are still in phase 
of academic interest in the veterinary medicine.  
Electromyography examinations revealed ab-
sence of lower motor affection encourages the lo-
calization of the process in the white matter of the 
spine. Spinal cord radiography, including myel-
ography is normal in cases of uncomplicated DM. 
Unfortunately myelography can be associate with 
declining of the clinical signs and has certain risks 
for some patients.(9) Genetic, metabolic, nutrition-
al, vascular and immune etiologic causes are sus-
pected, but without evidence of speciﬁ  c pathogen 
mechanisms. 
From many aspects DM has similarity with 
Multiplex sclerosis (МС) in the human population. 
Based on the latest information that refers to the 
МС, the conclusion is that DM is actually MC in 
dogs. (9)
CHARACTERISTICS OF THE CHANGES 
On affected dog’s necropsy, there are no macro-
scopic changes in the brain, spinal cord and periph-
eral nerves. Primary microscopic lesions are axons 
degenerations and axon loss. The degeneration is 
characterized with outspreading axons and myelin 
layers along the white matter. The degenerative 
changes that have been described in different dog 
breeds, refer to the white matter in the funiculus, 
dilatation of the myelin layer, inﬂ  ating axons and 
proper fragmentation and phagocytosis of the axons 
and myelin fragments (5,7,8). Reducer blue color-
ing by Luxol conﬁ   rms the myelin degeneration; 
changed astrocytes follow the degenerative changes. 
In the most of the studies in large breed dogs with 
DM, scattered single degenerations and ﬁ  ber loss 
are described without group incorporation inside 
the follicular parts of the axon. (7,8,9). All white 
matter folliculus are affected, with predomination in 
the lateral and dorsal folliculus, mostly around Т12 
(10). The lesions of the spinal cord are not symmet-
ric and are not limited. The pathological changes are 
more emphatic in the thoracic segments, and there is 
moderate degeneration in cervical and lumbar seg-
ments (11). The disease is thought to be sporadic 
and probably acquired.
Most of the DM studies in the large breed dogs 
described „scattered“individual ﬁ  ber degenerations 
and loss without group axon loss in certain regions 
(9). 
Clinical signs of DM include progressive ataxia, 
paresis and muscle atrophy of the lower limbs. Most 
dogs show little or no signs of spinal hyperpathia. 
There is still no effective treatment (3). 
Routine hematologic and chemistry proﬁ  les (to-
tal protein, albumins, urea, ALT, AP) are in normal 
ranges. In certain examinations in affected dogs me-
thionine deﬁ  ciency and changes in methionine syn-
thesis has been noticed, spatially in dogs fed with 
inner organs from ruminants (13).
The most of the necropsies revealed local hem-
orrhage and moderate enlargement in the   7 and 8 
thoracic segment from the spine. Cross section of 
the enlarged parts reveals dark-red, friable tin bor-
dered tissue; normal parenchyma repressed to Dura 
mater (12).
Dogs affected with DM have depressed lympho-
cyte blastogenesis. The depression of the immune 
cell response is in correlation with the clinical phase 
and severity of the disease. This suppression is pres-
ent due to genesis of the circulating suppressor cells. 
The immunoglobulins are on the borders of the le-
sions in the spine in dogs with DM (9). Imunohis-
tochemicals are proving of the immunoglobulins 
and deposition of the complement in the lesions of 
the spine reveals that these conditions are followed 
by disruption in the immune responses (15). Other 
investigations revealed that deﬁ  cit of vitamin E can 
be the reason, although the latest information indi-
cates that the genes of dog’s α-tocopherol transfer 
proteins are involved in the DM pathogenesis in 
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German shepherd dog (16). Other study in Siberian 
hacky dogs indicates possible involvement of the 
hereditary factor (6). 
Microscopic lesions of the nerve’s tissue are 
content of wide spine demyelization, with higher 
lesions concentration in the thoracic-lumbar part of 
the spine. In the more affected regions, there is a 
reduced number of axons and higher number of as-
troglial cells   and high density of teeny vascular ele-
ments. In some dogs there are similar lesions scat-
tered in the white matter of the brain. In many pa-
tients plasma cell inﬁ  ltrates are found in the kidneys 
through gastro-intestinal tract, provides evidence of 
immune failure -the reason for DM. (9)
THERAPY OPTIONS AND CONTROL 
OF THE DISEASE
There is no therapy for degenerative myelopa-
thy in dogs, but there are some measures that can 
be undertaken in order to decrease and to detain the 
progression of the disease. Walking and swimming 
can help the animal to maintain the muscle tone and 
the brain function.
Medications that can help in detaining the pro-
cess of the DM are aminocaproic acid (ЕАСА) and 
n-acetilcistein (NAC). It is considered that the amin-
ocaproic acid inhibits the deterioration of the myelin 
layer, while n-acetilcistein acts as antioxidant. Their 
application is not always successful (14). The ap-
plication of prednisolon in the ﬁ  rst 2 weeks of the 
disease can be useful, but also in the period of wors-
ening of the clinical signs (22).
Beside the medications, it’s very important the 
patient to be on special diet and vitamin and mineral 
supplement. Vitamins B complex are essential for 
the nerve function, vitamin С, Е and selen have anti-
oxidantive or protective function.  Vitamins В6 and 
В12 help in maintenance and strength of the myelin 
layer, protecting the nerves from damages.  Vitamin 
Е and Se are known as antioxidants. The difference 
is that Se doesn’t cross the blood-brain barrier, un-
like the vitamin E. From other side Se helps the 
function of vitamin E (9,14). In many cases, acu-
puncture gives good results, placing the needles in 
the right place releases the pain (9). 
In dogs affected by DM physical activity like 
walking and swimming has positive effect. Usu-
al movement of the dogs on proper distance and 
known trace not only improves the muscle tone, but 
improves the brain function, which can be very use-
ful in dogs suffering from senile dementia with DM 
(21). 
CONCLUSIONS 
Degeneration of the nerve tissue can appear as 
result of intoxication or metabolic disorder. Likely 
enough, many of the sporadic degenerative condi-
tions are with unknown background or suspicious 
diseases with unproved familiar/congenital ﬁ  nding, 
are acquired toxic or metabolic diseases.  
Generally, degenerative changes, including DM 
in dogs are relatively rear condition. After all these 
disorders have wide spectrum of changes, which 
basically are represents of important group of dis-
eases.  Degenerative myelopathy is very similar to 
МС in human and dogs are model for investigating 
of the pathogenesis of this disease. Sadly a little is 
known about this condition from clinical signs and 
clinical changes to pedigree relations (21). Newest 
diagnostic procedures are not available in practice; 
they can allow the veterinarians to research this dis-
ease on molecular level.   
There is a number of evidence showing that in 
many nerve-degenerative conditions, including the 
DM, exist common courses of molecular changes 
that appears besides the clinical and morphological 
signs. 
Characteristics of the disease on molecular level 
can help in the early diagnosis and opens odds for 
new therapeutic protocols.
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